CHARLOTTESVILLE, Va.,
Nov. 14, 2019 /PRNewswire-PRWeb/
-- ArcheMedX, the company improving clinical trial readiness,
today announced the expansion of its senior leadership team. To
support increasing demand for Ready, the company's clinical trials
platform, with sponsors and CROs, ArcheMedX has appointed
Kelly Ritch as Vice President of
Clinical Research Solutions. Kelly will apply her 20 years of
clinical operations experience to accelerate growth of the
company's clinical research business.
"As the complexity and cost of clinical research increases, a
key to reducing the risk of under-performing trials is ensuring the
preparedness of staff and sites" said Ms. Ritch. She added, "I'm
excited to join the ArcheMedX team and help clinical operations
leaders make faster, more informed decisions that improve trial
efficiency and outcomes."
Kelly is a dynamic and innovative executive adept at driving
high-performance and long-term value through the applied use of
software, data, and technology driven solutions for clinical
research. Her operational expertise and strategic mindset will
enable ArcheMedX to scale the capabilities it provides to a growing
customer base.
Nearly every clinical trial encounters operational challenges
and according to industry reports 86% of trials experience a study
startup delay and 72% of studies run more than one month behind
schedule. These delays can have significant financial costs for
each day that a trial impedes a product's development and
launch.
At ArcheMedX, we arm trial stakeholders with more than an
advanced training solution -- we provide the early warning
detection they need to mitigate operational risk and reduce costly
delays," said ArcheMedX CEO and co-founder Joel Selzer. "This is a pivotal time for the
clinical research sector, and we are thrilled to have an industry
leader with Kelly's breadth of experience join the team. With
Kelly's appointment we are better equipped to expand the product
and commercial strategies at ArcheMedX that will transform clinical
operations."
Kelly has previously led clinical data management, sales and
marketing, clinical trial operations, and strategic partnerships
with both sponsors and CROs. While creating and leading
high-performance teams across clinical research functions, Kelly
has had the opportunity to evaluate, implement, and develop a
number of key software platforms used to support and improve
clinical trial performance. Kelly has earned degrees from
University of Virginia, University of North Carolina Chapel Hill, and
University of Virginia Darden School of
Business.
--
About ArcheMedX
ArcheMedX applies behavioral science to transform learning and
generate actionable insights across the life sciences and
healthcare industries. Ready, the company's clinical trial
readiness platform, enables clinical research leaders to evaluate
and improve the preparedness of project teams and site personnel
and serves as an early warning detection system to reduce the risks
and costs associated with under-performing clinical trials. To
learn more about our operational intelligence and workforce
readiness solutions visit http://www.archemedx.com or follow
ArcheMedX on LinkedIn.
SOURCE ArcheMedX